Roland Diggelmann resigns as CEO of Roche Diagnostics after 10 years

By Sophie Chapman
Share
The Chief Executive Officer of the Swizerland-based drugmaker, Roche Diagnostics, has announced his resignation. Ronald Diggelmann will leave the compa...

The Chief Executive Officer of the Swizerland-based drugmaker, Roche Diagnostics, has announced his resignation.

Ronald Diggelmann will leave the company next month following working for the firm for a decade.

The CEO, 51, joined Roche Diagnostics’ parent company, Roche, in 2008. Digglemann has worked for the diagnostics unit since 2012.

Prior to his role as CEO, Diggelmann was appoint as the Region Head of Asia Pacific for Roche Diagnostics.

Michael Heuer, the firm’s Region Head of Europe, Middle East, Africa, and Latin America, will be appoint the interim CEO in September.

SEE ALSO:

“I am grateful to Roland Diggelmann for his many valuable contributions during his 10 years at Roche and I wish him all the best for the future,” stated Severin Schwan, CEO of Roche.

“I am pleased to appoint Michael Heuer as interim CEO of our Diagnostics Division.”

“Michael is a very respected leader with a wealth of experience in diagnostics.”

Heuer has worked in sales, marketing, and product develop positions in Europe and the US.

The soon-to-be CEO has also held the position of Head of Roche Near Patient Testing Business Area.

Share

Featured Articles

National Insurance: The Backbone of UK's Social Security

The UK's social security system is upheld by National Insurance (NI), a mandatory contribution, affecting most workers and employers. Here’s how it works

Lifetime of Achievement: Noel Anderson, American Red Cross

We celebrate Noel Anderson’s dedication to nonprofit humanitarianism & his leadership with the American Red Cross and beyond, at Sustainability LIVE London

Schneider Electric Powers Healthcare Facilities with Solar

Schneider Electric’s solar solutions are bringing healthcare to millions across Africa and India, as the company seeks to revolutionise rural healthcare

Apollo Hospitals’ Q2 Net Profit Soars by 63%

Hospitals

The Future of Cell Therapy for Thermo Fisher & Novo Nordisk

Medical Devices & Pharma

TikTok's Role in Healthcare: Safeguarding to Misinformation

Technology & AI